[시장보고서]세계의 PBM(Pharmacy Benefit Management) 시장 규모, 점유율, 동향 분석 : 비즈니스 모델별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

세계의 PBM(Pharmacy Benefit Management) 시장 규모, 점유율, 동향 분석 : 비즈니스 모델별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Pharmacy Benefit Management Market Size, Share & Trends Analysis Report By Business Model (Standalone PBM, Health Insurance Providers, Retail Pharmacy), By End Use (Commercial, Federal), By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1842278

리서치사 : Grand View Research

발행일 : 2025년 09월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,782,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,258,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,211,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

PBM(Pharmacy Benefit Management) : 시장 개요

세계의 PBM(Pharmacy Benefit Management) 시장 규모는 2024년에 7,470억 8,000만 달러로 평가되었으며, 2033년에는 1조 7,262억 7,000만 달러에 달할 것으로 예측되며, 2025년부터 2033년까지 CAGR은 9.9%로 성장할 전망입니다.

이러한 성장의 배경에는 의료 비용 절감 솔루션에 대한 수요 증가와 '가치 기반 의료' 및 결과 중심 의료 모델로의 전환이 있으며, 이에 따라 의료 서비스 제공자와 지불자가 PBM과 협력하여 복약 순응도를 높이고 처방을 최적화하며 더 나은 치료 결과를 보장하고자 하는 의지가 증가하고 있습니다. 더 나은 치료 결과를 확보하고자 하는 의지가 높아지고 있습니다.

또한, 신흥 시장의 규제 변화와 의료비 지출 증가가 시장 성장에 기여하고 있습니다.

처방약의 비용 상승과 치료의 복잡성

의약품 가격, 특히 특수 의약품과 혁신적 치료법의 가격이 계속 상승함에 따라, 의료 제공자와 지불자는 환자 치료를 희생하지 않고 비용을 절감해야 한다는 경제적 압박을 받고 있습니다. 동시에 첨단 생물학적 제제, 표적 치료제, 맞춤형 의료를 특징으로 하는 치료 요법도 복잡해지고 있습니다. 이러한 복잡성은 적절한 약물 선택, 투약, 환자의 순응도를 보장하기 위한 전문적인 관리가 필요합니다. PBM은 처방 설계, 약가 협상, 치료 결과 최적화를 위한 데이터 기반 전략 등의 전문성을 활용하여 이러한 과제를 해결하는 데 중요한 역할을 하고 있습니다.

불필요한 비용을 줄이면서 복잡한 현대 약리학을 탐색하는 PBM의 능력은 의료의 접근성을 개선하고 환자가 효과적인 치료를 받을 수 있도록 하는 데 필수적입니다.

주요 시장 진입 기업의 최근 동향과 영향 분석
기업/경쟁 분류
주요 기업의 시장 포지션 분석(2024년)
기업 리스트
- CVS Health
- Cigna
- Optum, Inc.
- MedImpact
- Anthem
- Change Healthcare
- Prime Therapeutics LLC
- HUB International Limited
- Elixir Rx Solutions LLC
- Express Scripts Canada

KSM

영문 목차

영문목차

Pharmacy Benefit Management Market Summary

The global pharmacy benefit management market size was estimated at USD 747.08 billion in 2024 and is projected to reach USD 1,726.27 billion by 2033, growing at a CAGR of 9.9% from 2025 to 2033. This growth is attributed to the growing demand for cost-containment solutions in healthcare, and the shift toward value-based care and outcomes-driven healthcare models, which have motivated providers and payers to collaborate with PBMs to improve medication adherence, optimize formularies, and ensure better therapeutic outcomes.

In addition, regulatory changes and rising healthcare spending in emerging markets contribute to market growth.

Rising Costs of Prescription Medications & Increasing Therapeutic Complexity

As pharmaceutical prices continue to rise, especially for specialty drugs and innovative therapies, healthcare providers and payers are under increasing financial pressure to control expenses without sacrificing patient care. Simultaneously, treatment regimens have grown more complex, characterized by advanced biologics, targeted therapies, and personalized medicine. This complexity requires specialized management to ensure appropriate drug selection, dosing, and patient adherence. PBMs play a vital role in tackling these challenges by utilizing their expertise in formulary design, negotiating drug prices, and employing data-driven strategies to optimize therapeutic outcomes.

PBMs' ability to navigate the complexities of modern pharmacology while reducing unnecessary costs makes them essential for improving healthcare affordability and ensuring patient access to effective treatments.

Global Pharmacy Benefit Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmacy benefit management market report based on business model, end-use, and region.

Business Model Outlook (Revenue, USD Billion, 2021 - 2033)
Standalone PBM
Health Insurance Providers
Retail Pharmacy
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Commercial
Federal
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Oceania
- Australia
- New Zealand
Rest of World

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Business Model
- 1.2.2. End-use
1.3. 1.3 Research Methodology
- 1.3.1. Commodity flow analysis
- 1.3.2. Information procurement
  - 1.3.2.1. Purchased database
  - 1.3.2.2. GVR'S internal database
  - 1.3.2.3. Primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Market Segmentation
2.3. Competitive Landscape

Chapter 3. Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTLE Analysis

Chapter 4. Pharmacy Benefit Management Market: Business Model Estimates & Trend Analysis

4.1. Pharmacy Benefit Management Market: Business Model Segment Dashboard
4.2. Business Model Movement & Market Share Analysis, 2024 & 2033
4.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by Business Model
- 4.3.1. Standalone PBM
  - 4.3.1.1. Standalone Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
- 4.3.2. Health Insurance Providers
  - 4.3.2.1. Health Insurance Providers Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
- 4.3.3. Retail Pharmacy
  - 4.3.3.1. Retail Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 5. Pharmacy Benefit Management Market: End-use Estimates & Trend Analysis

5.1. Pharmacy Benefit Management Market: End-use Segment Dashboard
5.2. End-use Movement & Market Share Analysis, 2024 & 2033
5.3. Global Pharmacy Benefit Management Market Size Estimates & Forecast, by End-use
- 5.3.1. Commercial
  - 5.3.1.1. Commercial Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)
- 5.3.2. Federal
  - 5.3.2.1. Federal Pharmacy Benefit Management Market, 2021 - 2033 (USD Billion)

Chapter 6. Pharmacy Benefit Management Market: Regional Estimates & Trend Analysis

6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
- 6.4.1. U.S.
  - 6.4.1.1. Key country dynamics
  - 6.4.1.2. Regulatory framework
  - 6.4.1.3. Competitive scenario
  - 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.4.2. Canada
  - 6.4.2.1. Key country dynamics
  - 6.4.2.2. Regulatory framework
  - 6.4.2.3. Competitive scenario
  - 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.4.3. Mexico
  - 6.4.3.1. Key country dynamics
  - 6.4.3.2. Regulatory framework
  - 6.4.3.3. Competitive scenario
  - 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
6.5. Europe
- 6.5.1. UK
  - 6.5.1.1. Key country dynamics
  - 6.5.1.2. Regulatory framework
  - 6.5.1.3. Competitive scenario
  - 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.2. Germany
  - 6.5.2.1. Key country dynamics
  - 6.5.2.2. Regulatory framework
  - 6.5.2.3. Competitive scenario
  - 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.3. France
  - 6.5.3.1. Key country dynamics
  - 6.5.3.2. Regulatory framework
  - 6.5.3.3. Competitive scenario
  - 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.4. Italy
  - 6.5.4.1. Key country dynamics
  - 6.5.4.2. Regulatory framework
  - 6.5.4.3. Competitive scenario
  - 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.5. Spain
  - 6.5.5.1. Key country dynamics
  - 6.5.5.2. Regulatory framework
  - 6.5.5.3. Competitive scenario
  - 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.6. Norway
  - 6.5.6.1. Key country dynamics
  - 6.5.6.2. Regulatory framework
  - 6.5.6.3. Competitive scenario
  - 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.7. Sweden
  - 6.5.7.1. Key country dynamics
  - 6.5.7.2. Regulatory framework
  - 6.5.7.3. Competitive scenario
  - 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.5.8. Denmark
  - 6.5.8.1. Key country dynamics
  - 6.5.8.2. Regulatory framework
  - 6.5.8.3. Competitive scenario
  - 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
6.6. Oceania
- 6.6.1. Australia
  - 6.6.1.1. Key country dynamics
  - 6.6.1.2. Regulatory framework
  - 6.6.1.3. Competitive scenario
  - 6.6.1.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
- 6.6.2. New Zealand
  - 6.6.2.1. Key country dynamics
  - 6.6.2.2. Regulatory framework
  - 6.6.2.3. Competitive scenario
  - 6.6.2.4. New Zealand market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market position analysis, 2024
7.4. List of Companies
- 7.4.1. CVS Health
  - 7.4.1.1. Company overview
  - 7.4.1.2. Financial performance
  - 7.4.1.3. Service benchmarking
  - 7.4.1.4. Strategic initiatives
- 7.4.2. Cigna
  - 7.4.2.1. Company overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Service benchmarking
  - 7.4.2.4. Strategic initiatives
- 7.4.3. Optum, Inc.
  - 7.4.3.1. Company overview
  - 7.4.3.2. Financial performance
  - 7.4.3.3. Service benchmarking
  - 7.4.3.4. Strategic initiatives
- 7.4.4. MedImpact
  - 7.4.4.1. Company overview
  - 7.4.4.2. Financial performance
  - 7.4.4.3. Service benchmarking
  - 7.4.4.4. Strategic initiatives
- 7.4.5. Anthem
  - 7.4.5.1. Company overview
  - 7.4.5.2. Financial performance
  - 7.4.5.3. Service benchmarking
  - 7.4.5.4. Strategic initiatives
- 7.4.6. Change Healthcare
  - 7.4.6.1. Company overview
  - 7.4.6.2. Financial performance
  - 7.4.6.3. Service benchmarking
  - 7.4.6.4. Strategic initiatives
- 7.4.7. Prime Therapeutics LLC
  - 7.4.7.1. Company overview
  - 7.4.7.2. Financial performance
  - 7.4.7.3. Service benchmarking
  - 7.4.7.4. Strategic initiatives
- 7.4.8. HUB International Limited
  - 7.4.8.1. Company overview
  - 7.4.8.2. Financial performance
  - 7.4.8.3. Service benchmarking
  - 7.4.8.4. Strategic initiatives
- 7.4.9. Elixir Rx Solutions LLC
  - 7.4.9.1. Company overview
  - 7.4.9.2. Financial performance
  - 7.4.9.3. Service benchmarking
  - 7.4.9.4. Strategic initiatives
- 7.4.10. Express Scripts Canada
  - 7.4.10.1. Company overview
  - 7.4.10.2. Financial performance
  - 7.4.10.3. Service benchmarking
  - 7.4.10.4. Strategic initiatives

한글목차

PBM(Pharmacy Benefit Management) : 시장 개요

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 PBM(Pharmacy Benefit Management) 시장 : 비즈니스 모델별 추정·동향 분석

제5장 PBM(Pharmacy Benefit Management) 시장 : 최종 용도별 추정·동향 분석

제6장 PBM(Pharmacy Benefit Management) 시장 : 지역별 추정·동향 분석

제7장 경쟁 구도